Press releases

2023

Jan 13, 2023
Ziphius Vaccines Appoints Former Head of Janssen Vaccines R&D as Chief Scientific Advisor

2022

Oct 7, 2022
Ziphius Vaccines and UZ Ghent Establish Unique Collaboration for GMP Manufacturing of saRNA-Based Vaccines
Jun 23, 2022
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
Jun 9, 2022
Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics
May 6, 2022
Ziphius Vaccines and Ghent University Publish Promising Data from self-amplifying RNA Platform in Molecular Therapy

2021

Sep 21, 2021
Ziphius Vaccines Accelerates its Promising sa-RNA Program with Two Senior Executive Appointments
May 25, 2021
Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing
Jan 11, 2021
Ziphius Vaccines strengthens Leadership Team and provides Business Update